Yasuyuki Mitani

542 total citations
14 papers, 426 citations indexed

About

Yasuyuki Mitani is a scholar working on Physiology, Pharmacology and Molecular Biology. According to data from OpenAlex, Yasuyuki Mitani has authored 14 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Yasuyuki Mitani's work include Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Analytical Chemistry and Chromatography (3 papers). Yasuyuki Mitani is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Analytical Chemistry and Chromatography (3 papers). Yasuyuki Mitani collaborates with scholars based in Japan and United States. Yasuyuki Mitani's co-authors include Junko Yarimizu, Nobuya Matsuoka, Hiroki Akashiba, Yoshitsugu Shitaka, Keni Ni, Hiroshi Uchino, Douglas P. Millay, Malgorzata E. Quinn, Rhonda Bassel‐Duby and Eric N. Olson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and The FASEB Journal.

In The Last Decade

Yasuyuki Mitani

14 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuyuki Mitani Japan 10 212 168 83 80 73 14 426
Leo W. Barrett United States 6 345 1.6× 309 1.8× 132 1.6× 58 0.7× 75 1.0× 8 580
Frederick J. Troendle United States 7 220 1.0× 312 1.9× 58 0.7× 66 0.8× 33 0.5× 9 540
Q.-X. Li Australia 7 138 0.7× 206 1.2× 110 1.3× 108 1.4× 41 0.6× 10 386
Stefanie Blättermann Germany 7 437 2.1× 65 0.4× 211 2.5× 147 1.8× 29 0.4× 7 664
Giulia Nesi Italy 12 218 1.0× 92 0.5× 29 0.3× 57 0.7× 46 0.6× 16 550
Nalini Vijay Gorantla India 14 216 1.0× 326 1.9× 71 0.9× 110 1.4× 62 0.8× 17 512
Ian Gurrell United Kingdom 11 176 0.8× 96 0.6× 47 0.6× 63 0.8× 39 0.5× 14 402
Marko Košiček Croatia 9 311 1.5× 350 2.1× 37 0.4× 27 0.3× 20 0.3× 13 595
Simon Heales United Kingdom 6 177 0.8× 220 1.3× 50 0.6× 35 0.4× 24 0.3× 8 416
William Z. Suo United States 13 321 1.5× 155 0.9× 164 2.0× 92 1.1× 47 0.6× 25 689

Countries citing papers authored by Yasuyuki Mitani

Since Specialization
Citations

This map shows the geographic impact of Yasuyuki Mitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuyuki Mitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuyuki Mitani more than expected).

Fields of papers citing papers by Yasuyuki Mitani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuyuki Mitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuyuki Mitani. The network helps show where Yasuyuki Mitani may publish in the future.

Co-authorship network of co-authors of Yasuyuki Mitani

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuyuki Mitani. A scholar is included among the top collaborators of Yasuyuki Mitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuyuki Mitani. Yasuyuki Mitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Suzuki, Takayuki, et al.. (2019). Discovery of N-ethylpyridine-2-carboxamide derivatives as a novel scaffold for orally active γ-secretase modulators. Bioorganic & Medicinal Chemistry. 28(1). 115132–115132. 8 indexed citations
3.
Fuji, Hideyoshi, et al.. (2017). Discovery of novel scaffolds for γ-secretase modulators without an arylimidazole moiety. Bioorganic & Medicinal Chemistry. 26(2). 435–442. 14 indexed citations
4.
Millay, Douglas P., Dilani G. Gamage, Malgorzata E. Quinn, et al.. (2016). Structure–function analysis of myomaker domains required for myoblast fusion. Proceedings of the National Academy of Sciences. 113(8). 2116–2121. 66 indexed citations
5.
Mitani, Yasuyuki, Ronald J. Vagnozzi, & Douglas P. Millay. (2016). In vivo myomaker‐mediated heterologous fusion and nuclear reprogramming. The FASEB Journal. 31(1). 400–411. 13 indexed citations
6.
Mitani, Yasuyuki, Hiroki Akashiba, Junko Yarimizu, et al.. (2013). Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates. Neuropharmacology. 79. 412–419. 5 indexed citations
7.
Mitani, Yasuyuki, et al.. (2012). Primary Anaplastic Large Cell Lymphoma of the Psoas Muscle: A Case Report and Literature Review. Acta Haematologica. 127(3). 186–188. 13 indexed citations
8.
Mitani, Yasuyuki, Junko Yarimizu, Hiroshi Uchino, et al.. (2012). Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice. Journal of Neuroscience. 32(6). 2037–2050. 149 indexed citations
9.
Mitani, Yasuyuki, Junko Yarimizu, Hiroki Akashiba, et al.. (2012). Amelioration of cognitive deficits in plaque‐bearing Alzheimer's disease model mice through selective reduction of nascent soluble A42 without affecting other A pools. Journal of Neurochemistry. 125(3). 465–472. 12 indexed citations
10.
Shitaka, Yoshitsugu, et al.. (2010). Progress in the development of anti-amyloid drugs for treatment of Alzheimer’s disease. Folia Pharmacologica Japonica. 136(1). 15–20. 3 indexed citations
11.
Mihara, Takuma, Kayoko Mihara, Junko Yarimizu, et al.. (2007). Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1 H)-one (ASP5854), in Models of Parkinson’s Disease and Cognition. Journal of Pharmacology and Experimental Therapeutics. 323(2). 708–719. 67 indexed citations
12.
Tozuka, Zenzaburo, Toshifumi Shiraga, Yasuyuki Mitani, et al.. (2003). Strategy for structural elucidation of drugs and drug metabolites using (MS)n fragmentation in an electrospray ion trap. Journal of Mass Spectrometry. 38(8). 793–808. 43 indexed citations
13.
Tozuka, Zenzaburo, et al.. (2002). Strategy for Structure Elucidation of Drug Metabolites Derived from Protonated Molecules and (MS)n Fragmentation of Zotepine, Tiaramide and their Metabolites. Drug Metabolism and Pharmacokinetics. 17(4). 316–339. 8 indexed citations
14.
Niwa, Toshiro, et al.. (2000). Stereoselective Metabolism of Cibenzoline, an Antiarrhythmic Drug, by Human and Rat Liver Microsomes: Possible Involvement of CYP2D and CYP3A. Drug Metabolism and Disposition. 28(9). 1128–1134. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leo W. Barrett Breakdown of academic impact, for papers by Frederick J. Troendle Breakdown of academic impact, for papers by Q.-X. Li Breakdown of academic impact, for papers by Stefanie Blättermann Breakdown of academic impact, for papers by Giulia Nesi Breakdown of academic impact, for papers by Nalini Vijay Gorantla Breakdown of academic impact, for papers by Ian Gurrell Breakdown of academic impact, for papers by Marko Košiček Breakdown of academic impact, for papers by Simon Heales Breakdown of academic impact, for papers by William Z. Suo
Rankless by CCL
2026